Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antegren

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Natalizumab (Tysabri, formerly known as Antegren, Elan Pharmaceuticals [Elan; San Francisco, CA, USA] and Biogen Idec [Biogen… Expand
Is this relevant?
Review
2004
Review
2004
Natalizumab (Antegren, Elan Corp. plc.; Biogen Idec.) is the first alpha4-integrin antagonist in the class of selective adhesion… Expand
Is this relevant?
2004
2004
In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2004
2004
Natalizumab (Antegren™, Elan Corp. plc.; Biogen Idec.) is the first α4-integrin antagonist in the class of selective adhesion… Expand
Is this relevant?
2002
2002
Antegren (Natalizumab) is a humanized monoclonal antibody directed against alpha 4-integrin. This antibody binds to the alpha 4… Expand
Is this relevant?
2002
2002
The 4 integrin, 4 7, plays an important role in recruiting circulating lymphocytes to the gastrointestinal tract, where its… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2002
2002
ZusammenfassungAntegren (Natalizumab) ist ein “humanisierter” monoklonaler Antikörper, der an die α4-Untereinheit von α4β1… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To determine the effect of humanized monoclonal antibody against alpha4 integrin (reactive with alpha4beta1 integrin or… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Objective: To determine the effect of humanized monoclonal antibody against α4 integrin (reactive with α4β1 integrin or very-late… Expand
Is this relevant?
1998
1998
AN-100226 (Antegren), a humanized monoclonal antibody (MAb) directed against the alpha4beta1 integrin (VLA-4) expressed on… Expand
Is this relevant?